XtalPi Holdings Limited is a Chinese biotechnology and technology company focused on applying advanced computation to drug discovery and materials research. Founded in 2015 by physicists from the Massachusetts Institute of Technology, the company operates an integrated research and development platform that combines quantum physics-based calculations, artificial intelligence models, high-performance cloud computing, and standardized robotic automation. XtalPi Holdings Limited primarily supports pharmaceutical companies in early-stage drug discovery, using its digital chemistry and AI-driven design tools to predict molecular structures and screen large libraries of compounds. Beyond pharmaceuticals, the company extends its technology to materials science and related fields, providing solutions for sectors such as energy, agricultural technology, new chemicals, and cosmetics. Through this platform-based model, XtalPi Holdings Limited plays a specialized role in enabling more data-driven, automated, and efficient research workflows across multiple science-driven industries worldwide.